Combining Dexamethasone and D-Methionine Provides Greater Protection Against Cisplatin- and Radiation-Induced Cytotoxicity in the Organ-of-Corti-Derived OC-k3 Cell Line: An In Vitro Study
Journal of Otorhinolaryngology, Hearing and Balance Medicine · 23.07.2026 · 7 (2) · 26
DOI: 10.3390/ohbm7020026 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Otorhinolaryngology, Hearing and Balance Medicine, online erschienen am 23.07.2026. Verfasst von Genevieve Min Lee und 10 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: SingHealth Duke-NUS Academic Medical Center, Joint Office of Academic Medicine.
Abstract (Originalsprache)
Background/Objectives: Nasopharyngeal cancer generally has a good survival rate with chemoradiotherapy, but a significant side effect is irreversible hearing loss, for which there is currently no preventive intervention. Given that dexamethasone (Dex) and D-methionine (dMet) have individually shown potential to prevent hearing loss in in vitro and animal studies, we hypothesized that combining Dex and dMet may offer greater protection against cytotoxicity induced by cisplatin and radiation treatments.
Methods
Organ-of-Corti-derived OC-k3 cells exposed to cisplatin and/or radiation were used as an in vitro model of treatment-induced cytotoxicity to investigate the protective mechanisms of Dex and dMet.
Results
Dex was associated with reduced apoptosis, accompanied by decreased p53 phosphorylation and increased Bcl-XL expression. Dex also reduced COX2 expression and showed trends toward attenuation of ERK1/2 and NFκB signaling. Conversely, dMet effectively blocked cisplatin-induced apoptosis but did not protect against radiation-induced cytotoxicity.
Conclusions
The combination of Dex and dMet provided greater protection against cisplatin- and radiation-induced cytotoxicity in the OC-k3 cells than either agent alone. These findings support further investigation of combined Dex and dMet as a potential strategy to mitigate treatment-induced ototoxicity.
Förderung
- SingHealth Duke-NUS Academic Medical Center
- Joint Office of Academic Medicine
Zitieren
APA
Lee, G. M., Tan, V. Y. J., Lim, C. M., Thong, J. F., Low, W. K., Dhillon, K. H., Teng, S. W., Zhang, E. Z., Low, C. Y. B., Kadir, H. B. A., & Tan, M. G. K. (2026). Combining Dexamethasone and D-Methionine Provides Greater Protection Against Cisplatin- and Radiation-Induced Cytotoxicity in the Organ-of-Corti-Derived OC-k3 Cell Line: An In Vitro Study. Journal of Otorhinolaryngology, Hearing and Balance Medicine, 7(2), 26. https://doi.org/10.3390/ohbm7020026
Vancouver
Lee GM, Tan VYJ, Lim CM, Thong JF, Low WK, Dhillon KH, et al. Combining Dexamethasone and D-Methionine Provides Greater Protection Against Cisplatin- and Radiation-Induced Cytotoxicity in the Organ-of-Corti-Derived OC-k3 Cell Line: An In Vitro Study. Journal of Otorhinolaryngology, Hearing and Balance Medicine. 2026;7(2):26. doi:10.3390/ohbm7020026
BibTeX
@article{Lee2026,
author = {Lee, Genevieve Min and Tan, Vanessa Yee Jueen and Lim, Chwee Ming and Thong, Jiun Fong and Low, Wong Kein and Dhillon, Kaman H. and Teng, Siaw Wei and Zhang, Edward Zhiyong and Low, Clara Ying Bei and Kadir, Hanis Binte Abdul and Tan, Michelle Guet Khim},
title = {Combining Dexamethasone and D-Methionine Provides Greater Protection Against Cisplatin- and Radiation-Induced Cytotoxicity in the Organ-of-Corti-Derived OC-k3 Cell Line: An In Vitro Study},
journal = {Journal of Otorhinolaryngology, Hearing and Balance Medicine},
year = {2026},
volume = {7},
number = {2},
pages = {26},
doi = {10.3390/ohbm7020026}
}
EUVIMED